OKUR
OnKure Therapeutics, Inc.
There isn't enough reported data to score OKUR yet.
OKUR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
OKUR's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
OKUR PE Valuation
OKUR has no meaningful PE right now: it lost money over the past year.
OKUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect OKUR's losses to shrink, with revenue declining.
OKUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.76 | +$10.74 |
| Q2 2026 | -$3.49 | +$10.02 |
| Q1 2026 | -$4.32 | +$9.65 |
| Q4 2025 | -$4.40 | +$10.88 |
| Q3 2025 | -$13.50 | -$1.30 |
| Q2 2025 | -$13.51 | +$3.29 |
| Q1 2025 | -$13.97 | +$7.73 |
| Q4 2024 | -$15.28 | +$9.92 |
OKUR is still losing money, but far less than before: $2.76 per share over the past year, against $25.20 at its worst in late 2023.
OKUR Quarterly Revenue
OKUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13.1M | -$71K |
| Q2 2026 | -$10.4M | +$2.9M |
| Q1 2026 | -$12.9M | +$1.1M |
| Q4 2025 | -$11.5M | +$9.5M |
| Q3 2025 | -$13M | -$10.8M |
| Q4 2024 | -$21.1M | -$1.3M |
| Q3 2024 | -$2.3M | +$16.5M |
| Q4 2023 | -$19.8M | -$3.9M |
OKUR has burned cash in almost every quarter: −$48M over the past year, against −$61M the year before.
OKUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +59K shares |
| 1 year | +269% | +36.4M shares |
| 3 years | +1377% | +46.5M shares |
| 5 years | +2237% | +47.8M shares |
OKUR has 50M diluted shares, up 269% from a year ago.
OKUR Net Leverage
OKUR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OKUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 33.5 | Neutral |
OKUR's weekly RSI is 45 (neutral) and its Stochastic is 34 (neutral).
OKUR PE vs Healthcare Sector
OKUR has no meaningful PE right now: it lost money over the past year.
OKUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.62 | 15% above |
| 20 week MA | $3.37 | 11% below |
| 50 week MA | $3.51 | 14% below |
| 100 week MA | $3.59 | 16% below |
| 200 week MA | $21.5 | 86% below |
OKUR has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 86% below its 200-week average.
OKUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $138.9 | $89.5 | -36% |
| 2022 | $89.5 | $21.9 | -76% |
| 2023 | $21.9 | $16.0 | -27% |
| 2024 | $16.0 | $8.16 | -49% |
| 2025 | $8.16 | $2.80 | -66% |
| 2026 YTD | $2.80 | $3.01 | +7.5% |
OKUR has finished every year since 2021 lower, and it's up 7.5% so far in 2026.